Global OTC Drug Market Research Report 2021

1 OTC Drug Market Overview

• 1.1 Product Overview and Scope of OTC Drug
• 1.2 OTC Drug Segment by Type
  • 1.2.1 Global OTC Drug Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Class A
  • 1.2.3 Class B
• 1.3 OTC Drug Segment by Application
  • 1.3.1 OTC Drug Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Household
• 1.4 Global OTC Drug Market Size Estimates and Forecasts
  • 1.4.1 Global OTC Drug Revenue 2016-2027
  • 1.4.2 Global OTC Drug Sales 2016-2027
  • 1.4.3 OTC Drug Market Size by Region: 2016 Versus 2021 Versus 2027

2 OTC Drug Market Competition by Manufacturers

• 2.1 Global OTC Drug Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global OTC Drug Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global OTC Drug Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers OTC Drug Manufacturing Sites, Area Served, Product Type
• 2.5 OTC Drug Market Competitive Situation and Trends
  • 2.5.1 OTC Drug Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest OTC Drug Players Market Share by Revenue
  • 2.5.3 Global OTC Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 OTC Drug Retrospective Market Scenario by Region

• 3.1 Global OTC Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global OTC Drug Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America OTC Drug Market Facts & Figures by Country
  • 3.3.1 North America OTC Drug Sales by Country
  • 3.3.2 North America OTC Drug Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe OTC Drug Market Facts & Figures by Country
  • 3.4.1 Europe OTC Drug Sales by Country
  • 3.4.2 Europe OTC Drug Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific OTC Drug Market Facts & Figures by Region
  • 3.5.1 Asia Pacific OTC Drug Sales by Region
  • 3.5.2 Asia Pacific OTC Drug Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America OTC Drug Market Facts & Figures by Country
  • 3.6.1 Latin America OTC Drug Sales by Country
  • 3.6.2 Latin America OTC Drug Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa OTC Drug Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa OTC Drug Sales by Country
  • 3.7.2 Middle East and Africa OTC Drug Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global OTC Drug Historic Market Analysis by Type

• 4.1 Global OTC Drug Sales Market Share by Type (2016-2021)
• 4.2 Global OTC Drug Revenue Market Share by Type (2016-2021)
• 4.3 Global OTC Drug Price by Type (2016-2021)

5 Global OTC Drug Historic Market Analysis by Application

• 5.1 Global OTC Drug Sales Market Share by Application (2016-2021)
• 5.2 Global OTC Drug Revenue Market Share by Application (2016-2021)
• 5.3 Global OTC Drug Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Bayer HealthCare
  • 6.1.1 Bayer HealthCare Corporation Information
  • 6.1.2 Bayer HealthCare Description and Business Overview
  • 6.1.3 Bayer HealthCare OTC Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Bayer HealthCare Product Portfolio
  • 6.1.5 Bayer HealthCare Recent Developments/Updates
• 6.2 GlaxoSmithKline (GSK)
  • 6.2.1 GlaxoSmithKline (GSK) Corporation Information
  • 6.2.2 GlaxoSmithKline (GSK) Description and Business Overview
  • 6.2.3 GlaxoSmithKline (GSK) OTC Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 GlaxoSmithKline (GSK) Product Portfolio
  • 6.2.5 GlaxoSmithKline (GSK) Recent Developments/Updates
• 6.3 Johnson&Johnson
  • 6.3.1 Johnson&Johnson Corporation Information
  • 6.3.2 Johnson&Johnson Description and Business Overview
  • 6.3.3 Johnson&Johnson OTC Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Johnson&Johnson Product Portfolio
  • 6.3.5 Johnson&Johnson Recent Developments/Updates
• 6.4 Pfizer
  • 6.4.1 Pfizer Corporation Information
  • 6.4.2 Pfizer Description and Business Overview
  • 6.4.3 Pfizer OTC Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Pfizer Product Portfolio
  • 6.4.5 Pfizer Recent Developments/Updates
• 6.5 Sanofi
  • 6.5.1 Sanofi Corporation Information
  • 6.5.2 Sanofi Description and Business Overview
  • 6.5.3 Sanofi OTC Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Sanofi Product Portfolio
  • 6.5.5 Sanofi Recent Developments/Updates
• 6.6 AstraZeneca
  • 6.6.1 AstraZeneca Corporation Information
  • 6.6.2 AstraZeneca Description and Business Overview
  • 6.6.3 AstraZeneca OTC Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 AstraZeneca Product Portfolio
  • 6.6.5 AstraZeneca Recent Developments/Updates
• 6.7 BioGaia
  • 6.6.1 BioGaia Corporation Information
  • 6.6.2 BioGaia Description and Business Overview
  • 6.6.3 BioGaia OTC Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 BioGaia Product Portfolio
  • 6.7.5 BioGaia Recent Developments/Updates
• 6.8 Bristol Myers Squibb
  • 6.8.1 Bristol Myers Squibb Corporation Information
  • 6.8.2 Bristol Myers Squibb Description and Business Overview
  • 6.8.3 Bristol Myers Squibb OTC Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Bristol Myers Squibb Product Portfolio
  • 6.8.5 Bristol Myers Squibb Recent Developments/Updates
• 6.9 Bukwang Pharmaceutica
  • 6.9.1 Bukwang Pharmaceutica Corporation Information
  • 6.9.2 Bukwang Pharmaceutica Description and Business Overview
  • 6.9.3 Bukwang Pharmaceutica OTC Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Bukwang Pharmaceutica Product Portfolio
  • 6.9.5 Bukwang Pharmaceutica Recent Developments/Updates
• 6.10 Chr. Hansen
  • 6.10.1 Chr. Hansen Corporation Information
  • 6.10.2 Chr. Hansen Description and Business Overview
  • 6.10.3 Chr. Hansen OTC Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Chr. Hansen Product Portfolio
  • 6.10.5 Chr. Hansen Recent Developments/Updates
• 6.11 Cipla
  • 6.11.1 Cipla Corporation Information
  • 6.11.2 Cipla OTC Drug Description and Business Overview
  • 6.11.3 Cipla OTC Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Cipla Product Portfolio
  • 6.11.5 Cipla Recent Developments/Updates
• 6.12 CoLucid
  • 6.12.1 CoLucid Corporation Information
  • 6.12.2 CoLucid OTC Drug Description and Business Overview
  • 6.12.3 CoLucid OTC Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 CoLucid Product Portfolio
  • 6.12.5 CoLucid Recent Developments/Updates
• 6.13 Daiichi Sankyo
  • 6.13.1 Daiichi Sankyo Corporation Information
  • 6.13.2 Daiichi Sankyo OTC Drug Description and Business Overview
  • 6.13.3 Daiichi Sankyo OTC Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Daiichi Sankyo Product Portfolio
  • 6.13.5 Daiichi Sankyo Recent Developments/Updates
• 6.14 Friggs
  • 6.14.1 Friggs Corporation Information
  • 6.14.2 Friggs OTC Drug Description and Business Overview
  • 6.14.3 Friggs OTC Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Friggs Product Portfolio
  • 6.14.5 Friggs Recent Developments/Updates
• 6.15 DSM
  • 6.15.1 DSM Corporation Information
  • 6.15.2 DSM OTC Drug Description and Business Overview
  • 6.15.3 DSM OTC Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 DSM Product Portfolio
  • 6.15.5 DSM Recent Developments/Updates
• 6.16 Eisai
  • 6.16.1 Eisai Corporation Information
  • 6.16.2 Eisai OTC Drug Description and Business Overview
  • 6.16.3 Eisai OTC Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Eisai Product Portfolio
  • 6.16.5 Eisai Recent Developments/Updates
• 6.17 Eli Lilly
  • 6.17.1 Eli Lilly Corporation Information
  • 6.17.2 Eli Lilly OTC Drug Description and Business Overview
  • 6.17.3 Eli Lilly OTC Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Eli Lilly Product Portfolio
  • 6.17.5 Eli Lilly Recent Developments/Updates
• 6.18 Herbalife
  • 6.18.1 Herbalife Corporation Information
  • 6.18.2 Herbalife OTC Drug Description and Business Overview
  • 6.18.3 Herbalife OTC Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 Herbalife Product Portfolio
  • 6.18.5 Herbalife Recent Developments/Updates
• 6.19 Euradite
  • 6.19.1 Euradite Corporation Information
  • 6.19.2 Euradite OTC Drug Description and Business Overview
  • 6.19.3 Euradite OTC Drug Sales, Revenue and Gross Margin (2016-2021)
  • 6.19.4 Euradite Product Portfolio
  • 6.19.5 Euradite Recent Developments/Updates

7 OTC Drug Manufacturing Cost Analysis

• 7.1 OTC Drug Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of OTC Drug
• 7.4 OTC Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 OTC Drug Distributors List
• 8.3 OTC Drug Customers

9 OTC Drug Market Dynamics

• 9.1 OTC Drug Industry Trends
• 9.2 OTC Drug Growth Drivers
• 9.3 OTC Drug Market Challenges
• 9.4 OTC Drug Market Restraints

10 Global Market Forecast

• 10.1 OTC Drug Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of OTC Drug by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of OTC Drug by Type (2022-2027)
• 10.2 OTC Drug Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of OTC Drug by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of OTC Drug by Application (2022-2027)
• 10.3 OTC Drug Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of OTC Drug by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of OTC Drug by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List